ENTRY       K15413                      KO
NAME        SP100
DEFINITION  nuclear autoantigen Sp-100
PATHWAY     ko05168  Herpes simplex infection
            ko05203  Viral carcinogenesis
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Human Diseases
              Cancers
               05203 Viral carcinogenesis
                K15413  SP100; nuclear autoantigen Sp-100
              Infectious diseases
               05168 Herpes simplex infection
                K15413  SP100; nuclear autoantigen Sp-100
GENES       HSA: 6672(SP100)
            PTR: 450184(SP100)
            PPS: 100980555(SP100)
            GGO: 101145156
            PON: 100171661(SP100)
            MCC: 711005(SP100)
            MCF: 102147042(SP100)
            MMU: 20684(Sp100)
            HGL: 101725529(Sp100)
            TUP: 102477359(SP100)
            CFA: 477402(SP100)
            FCA: 101093955(SP100)
            PTG: 102972942(SP100)
            BTA: 100140338(SP100)
            BOM: 102272791(SP140L) 102273079(SP100)
            PHD: 102343699(SP140L) 102344064(SP100)
            CHX: 102175070 102186814
            SSC: 100516940(SP100)
            CFR: 102520119(SP100)
            BACU: 103004719(SP100)
            LVE: 103072287(SP140L) 103088206(SP100)
            ECB: 100630207(SP100)
            MYB: 102242354 102248420
            MYD: 102752939 102753211(SP100)
            PALE: 102897738(SP100)
REFERENCE   PMID:17343971
  AUTHORS   Everett RD, Chelbi-Alix MK
  TITLE     PML and PML nuclear bodies: implications in antiviral defence.
  JOURNAL   Biochimie 89:819-30 (2007)
///
